Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 6/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.52 |
| ▸ | CYP2J2 | P51589 | 3/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.47 |
| ▸ | LIPE | Q05469 | 2/20 | 0.46 |
| ▸ | KIT | P10721 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
| ▸ | SCD | O00767 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.44 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 2/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13873771 | 0.90 | EPHX2 (0.57) | EPHX2CYP2C9CYP2J2LOXL2S1PR3 | |
| SCHEMBL13873763 | 0.89 | EPHX2 (0.61) | EPHX2CYP2C9CYP2J2LOXL2S1PR3 | |
| SCHEMBL13873789 | 0.85 | EPHX2 (0.59) | EPHX2CYP2C9CYP2J2S1PR3LIPE | |
| SCHEMBL13873825 | 0.83 | EPHX2 (0.55) | EPHX2CYP2C9CYP2J2S1PR3LIPE | |
| SCHEMBL13873755 | 0.82 | EPHX2 (0.57) | EPHX2CYP2C9CYP2J2S1PR3KIT | |
| SCHEMBL13874899 | 0.80 | EPHX2 (0.57) | EPHX2CYP2C9CYP2J2LOXL2KIT | |
| SCHEMBL13873442 | 0.78 | EPHX2 (0.82) | EPHX2CYP2C9CYP2J2CYP2C19 | |
| SCHEMBL13873705 | 0.78 | NAMPT (0.52) | EPHX2CYP2C9KITSCN5ASCN9A | |
| SCHEMBL13873859 | 0.76 | MEN1 (0.54) | CYP2C9KITCYP2C19GRIN2BNAMPT | |
| SCHEMBL13873543 | 0.76 | EPHX2 (0.60) | EPHX2CYP2C9CYP2J2CYP2C19GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090111791-A1 | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-30 | — | — | US | disclosed |
| US-20090111791-A1 | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111791-A1 | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same | EPHX1, EPHX2, NCEH1 | EPHX2 2/4885CYP2C9 477/4885CYP2J2 405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.